APA (7th ed.) Citation

BL, H., Y, G., CW, M., MF, W., AJ, R., TO, S., . . . JA, J. (2016). CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease. Journal of neurosurgery, 124(6), 1746. https://doi.org/10.3171/2015.6.JNS15795

Chicago Style (17th ed.) Citation

BL, Hoh, et al. "CYP2C19 and CES1 Polymorphisms and Efficacy of Clopidogrel and Aspirin Dual Antiplatelet Therapy in Patients with Symptomatic Intracranial Atherosclerotic Disease." Journal of Neurosurgery 124, no. 6 (2016): 1746. https://doi.org/10.3171/2015.6.JNS15795.

MLA (9th ed.) Citation

BL, Hoh, et al. "CYP2C19 and CES1 Polymorphisms and Efficacy of Clopidogrel and Aspirin Dual Antiplatelet Therapy in Patients with Symptomatic Intracranial Atherosclerotic Disease." Journal of Neurosurgery, vol. 124, no. 6, 2016, p. 1746, https://doi.org/10.3171/2015.6.JNS15795.